The Institute of Medicine has proposed the FDA create a central management plan for every new drug to strengthen oversight of drugs over the entire life cycle.
Read the full report in Becker’s Hospital Review on the IOM report.
The Institute of Medicine has proposed the FDA create a central management plan for every new drug to strengthen oversight of drugs over the entire life cycle.
Read the full report in Becker’s Hospital Review on the IOM report.
